AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2005
Feb 11, 2005
30786_dirs_2005-02-11_f83bb4cb-2c86-47e7-b161-33c2fdeaca08.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO)
CIK: 0000012208
Period of Report: 2005-02-09
Reporting Person: CRUTCHFIELD BRADFORD (Vice President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-02-09 | Incentive Stock Option (right to buy) | $57.49 | A | 1400 | Acquired | 2015-02-09 | Bio-Rad A Common Stock (1400) | Direct |
| 2005-02-09 | Non-Qualified Stock Option (right to buy) | $57.49 | A | 5600 | Acquired | 2015-02-09 | Bio-Rad A Common Stock (5600) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 2924 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $10.75 | 2010-09-19 | Bio-Rad A Common Stock (10200) | 10200 | Direct |
| Incentive Stock Option (right to buy) | $28.61 | 2012-02-06 | Bio-Rad A Common Stock (4000) | 4000 | Direct |
| Incentive Stock Option (right to buy) | $35.5 | 2013-02-05 | Bio-Rad A Common Stock (8870) | 8870 | Direct |
| Incentive Stock Option (right to buy) | $53.75 | 2014-02-04 | Bio-Rad A Common Stock (2738) | 2738 | Direct |
| Non-Qualified Stock Option (right to buy) | $35.5 | 2013-02-05 | Bio-Rad A Common Stock (1130) | 1130 | Direct |
| Non-Qualified Stock Option (right to buy) | $53.75 | 2014-02-04 | Bio-Rad A Common Stock (5262) | 5262 | Direct |
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13